Phoenix Biotech PBAXU Stock
Phoenix Biotech Price Chart
Phoenix Biotech PBAXU Financial and Trading Overview
Phoenix Biotech stock price | 10.37 USD |
Previous Close | 10.86 USD |
Open | 10.77 USD |
Bid | 0 USD x 800 |
Ask | 0 USD x 1400 |
Day's Range | 10.86 - 10.86 USD |
52 Week Range | 9.87 - 11.73 USD |
Volume | 600 USD |
Avg. Volume | 90 USD |
Market Cap | N/A |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | 0 USD |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
PBAXU Valuation Measures
Enterprise Value | 73.65M USD |
Trailing P/E | N/A |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | N/A |
Price/Book (mrq) | N/A |
Enterprise Value/Revenue | N/A |
Enterprise Value/EBITDA | N/A |
Trading Information
Phoenix Biotech Stock Price History
Beta (5Y Monthly) | N/A |
52-Week Change | 7.66% |
S&P500 52-Week Change | 20.43% |
52 Week High | 11.73 USD |
52 Week Low | 9.87 USD |
50-Day Moving Average | 11 USD |
200-Day Moving Average | 10.45 USD |
PBAXU Share Statistics
Avg. Volume (3 month) | 90 USD |
Avg. Daily Volume (10-Days) | 280 USD |
Shares Outstanding | N/A |
Float | 1.47M |
Short Ratio | 10.85 |
% Held by Insiders | 0% |
% Held by Institutions | 7.29% |
Shares Short | 141 |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | N/A |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 0% |
Operating Margin (ttm) | 0% |
Gross Margin | 0% |
EBITDA Margin | 0% |
Management Effectiveness
Return on Assets (ttm) | N/A |
Return on Equity (ttm) | N/A |
Income Statement
Revenue (ttm) | N/A |
Revenue Per Share (ttm) | N/A |
Quarterly Revenue Growth (yoy) | N/A |
Gross Profit (ttm) | N/A |
EBITDA | N/A |
Net Income Avi to Common (ttm) | -771451 USD |
Diluted EPS (ttm) | N/A |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 178.09K USD |
Total Cash Per Share (mrq) | 0.03 USD |
Total Debt (mrq) | 650K USD |
Total Debt/Equity (mrq) | N/A |
Current Ratio (mrq) | 4.382 |
Book Value Per Share (mrq) | -1.71 |
Cash Flow Statement
Operating Cash Flow (ttm) | -981933 USD |
Levered Free Cash Flow (ttm) | N/A |
Profile of Phoenix Biotech
Country | United States |
State | CA |
City | Oakland |
Address | 2201 Broadway |
ZIP | 94612 |
Phone | 215 731 9450 |
Website | https://www.phoenixbiotechacquisitioncorp.com |
Industry | Shell Companies |
Sector(s) | Financial Services |
Full Time Employees | N/A |
Phoenix Biotech Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It engages in identifying and acquiring a business that focuses on the healthcare or healthcare related industries in the United States and Europe. Phoenix Biotech Acquisition Corp. was incorporated in 2021 and is based in Oakland, California.
Q&A For Phoenix Biotech Stock
What is a current PBAXU stock price?
Phoenix Biotech PBAXU stock price today per share is 10.37 USD.
How to purchase Phoenix Biotech stock?
You can buy PBAXU shares on the NasdaqGM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Phoenix Biotech?
The stock symbol or ticker of Phoenix Biotech is PBAXU.
Which industry does the Phoenix Biotech company belong to?
The Phoenix Biotech industry is Shell Companies.
How many shares does Phoenix Biotech have in circulation?
The max supply of Phoenix Biotech shares is 0.
What is Phoenix Biotech Price to Earnings Ratio (PE Ratio)?
Phoenix Biotech PE Ratio is 0.00000000 now.
What was Phoenix Biotech earnings per share over the trailing 12 months (TTM)?
Phoenix Biotech EPS is 0 USD over the trailing 12 months.
Which sector does the Phoenix Biotech company belong to?
The Phoenix Biotech sector is Financial Services.